We sit down with the founders poised to be the next big disruptors in the space industry. Here we chat with Will Edwards, CEO of Firehawk Aerospace, a custom rocket engine design and manufacturing company.
We sit down with the founders poised to be the next big disruptors in the space industry. Here we chat with Will Edwards, CEO of Firehawk Aerospace, a custom rocket engine design and manufacturing company.
Periodic bear markets are inevitable, but they're less unpleasant if you're prepared before they arrive.
Mat Ryan has vowed to push Bernd Leno all the way after joining Arsenal from Brighton. Ryan has joined the Gunners on loan until the end of the season, with the club not having the option to make the deal permanent in the summer. The Australian will come in and be a back-up to first-choice Arsenal goalkeeper Leno, with Alex Runarsson possibly heading out on loan.
Walgreens has administered more than 1 million COVID-19 vaccinations across long-term care facilities and other vulnerable populations identified as part of state and jurisdiction distribution plans. The company also remains on track to complete the administration of COVID-19 vaccine first doses in skilled nursing facilities by Monday, Jan. 25.
The "Global Petroleum Sorbent Pads Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
Eligible students will receive up to $25k and professional development trainingWASHINGTON, Jan. 22, 2021 (GLOBE NEWSWIRE) -- A $5 million gift from 3M to UNCF (United Negro College Fund) will create a new multi-year need-based scholarship program to support more than 100 Saint Paul, MN, students as they embark on STEM-related studies at Historically Black Colleges and Universities or at Florida International University (FIU). The UNCF 3M Science. Applied to Life. TM Scholarship Program is open to underrepresented minority high school seniors attending Saint Paul Public Schools or charter schools serving St. Paul students and current first-year college students attending an HBCU or FIU who graduated from Saint Paul Public Schools or Saint Paul-serving charter schools. Over the next four years, up to 29 students majoring in STEM-related studies will be selected to receive scholarships and will be eligible to receive up to $25,000 over the four-year period, with funding available for emergency aid. During the summer months, scholarship recipients will engage with 3M, learning first-hand from executives about their career journey, experiences and roles within the company. The intent is to create connections between UNCF scholars and 3M employee mentors. “UNCF is excited to work with 3M to launch this new opportunity for students in the Twin Cities who plan to attend our nation’s HBCUs,” said Dr. Michael Lomax, UNCF president and CEO. “The scholarship and career development will change the lives of many students who may not have the financial means to further their education after earning a high school diploma. With this support, more students from Saint Paul will have the opportunity to earn their STEM degrees and begin meaningful careers in the 21st century workforce.” Twenty-five percent of STEM degrees earned by African American graduates are earned at HBCUs. HBCUs graduated 46% of Black women who earned degrees in STEM disciplines between 1995 and 2004. Eight HBCUs were among the top 20 institutions to award the most science and engineering bachelor’s degrees to Black graduates from 2008-2012. HBCUs are the institution of origin among almost 30% of Black graduates of science and engineering doctorate programs. Even with recent growth in the field, statistics regarding African Americans in STEM fields show their white and non-Black counterparts outpace them in key positions. Black and white students pursue STEM degrees at similar rates, but Black students in STEM fields do not attain comparable representation as it relates to their degree attainment. This new partnership with UNCF and 3M aims to bolster more underrepresented students into STEM professions. “As part of our commitment to advancing social justice, we’re incredibly proud to partner with Saint Paul Public Schools and UNCF to provide STEM scholarships for students to attend Historically Black Colleges and Universities,” said 3M’s Chief Equity Officer, James Momon. “This collaboration is one of many milestones in our efforts toward creating greater equity for underrepresented populations.” This partnership with UNCF is one part of 3M’s $50 million commitment to address racial opportunity gaps in STEM and Skilled Trades education. The company seeks to leverage its full capabilities, including philanthropy, to support more equitable outcomes for marginalized populations. "Saint Paul Public Schools is grateful to 3M and UNCF for providing this opportunity to our high school graduates who aspire to pursue a STEM career at HBCUs," said Superintendent Joe Gothard. "These scholarships will open doors that may not otherwise be available to our students and set them on a path to success in college and beyond." Scholarship applications are due by May 10, 2021. Scholarships will be awarded and administered by UNCF. Recipients will be notified by August 2021. Visit UNCF.org/3MScholarship to apply. ### About UNCF UNCF (United Negro College Fund) is the nation’s largest and most effective minority education organization. To serve youth, the community and the nation, UNCF supports students’ education and development through scholarships and other programs, strengthens its 37 member colleges and universities, and advocates for the importance of minority education and college readiness. UNCF institutions and other historically Black colleges and universities are highly effective, awarding nearly 20 percent of African American baccalaureate degrees. Today, UNCF supports more than 60,000 students at more than 1,100 colleges and universities across the country. Its logo features the UNCF torch of leadership in education and its widely recognized motto, “A mind is a terrible thing to waste.”® Learn more at UNCF.org, or for continuous updates and news, follow UNCF on Twitter at @UNCF. About 3M At 3M (NYSE: MMM), we apply science in collaborative ways to improve lives daily as our employees connect with customers all around the world. Learn more about 3M's creative solutions to global challenges at www.3M.com or on Twitter @3M or @3MNews. About Saint Paul Public Schools Saint Paul Public Schools (SSPS) is one of Minnesota’s largest school districts with more than 36,000 students. Highly trained and deeply dedicated staff, cutting-edge academic programs, and strong community support are among the district’s hallmarks. Our student population is diverse, with students who speak more than 125 languages and dialects. Our Mission: Inspire students to think critically, pursue their dreams and change the world. CONTACT: Khalilah Long United Negro College Fund, Inc. (UNCF) 301.633.3928 firstname.lastname@example.org
Sierra Bancorp Declares Quarterly Cash Dividend
This communications infrastructure giant has a performance record and future prospects that say yes.
Brandon Hall Group, the leader in Empowering, Recognizing and Certifying Excellence in HCM recently announced that Totara is certified as a Smartchoice® Preferred Solution Provider. This recognizes Totara’s delivery of adaptive learning technology to help organizations build a better workplace, increase resilience and prosper in today’s fast-changing world. Boca Raton, FL, Jan. 22, 2021 (GLOBE NEWSWIRE) -- After an extensive review Brandon Hall Group, confirms that Totara is living their mission to develop and engage talent to drive enterprise success. Totara builds learning, employee engagement and performance management technologies that enable large multinational corporations, government entities and mid-market companies to deliver enterprise-level talent and workforce experiences. “Today ‘always-on’ is the default work setting for most employees, both in the office and when we’re working remotely,” said Michael Rochelle, Chief Strategy Officer and Principal HCM Analyst at Brandon Hall Group. “Totara recognized this trend years ago when they first launched Totara Learn. Their latest suite of platforms reflects Totara’s commitment to continuously adapt their solutions to position organizations and employees for success, both today and in preparation for the future. Totara’s focus on enabling collaboration, continuous performance and innovation, and tackling these challenges with an integrated approach, is what organizations need in these uncertain times.” The analyst team at Brandon Hall Group has spent years better understanding Totara as well as the market they operate. The team has conducted in-depth briefings with the product teams, reviewed case studies and collected customer feedback to certify they deliver upon their message. The Preferred Provider Program provides a world-class membership center for knowledge, resources and advisory support to the entire Totara organization. During this time Brandon Hall Group conducted a full review of Totara product/service messaging and website, collateral marketing material and social media strategy. “We are delighted to be recognized as a Smartchoice® Preferred Provider by the Brandon Hall Group,” said Richard Wyles, Chief Executive Officer of Totara. “Top-performing organizations understand that learning and performance management must be tightly interwoven, but the myriad of systems that organizations rely on to support these critical learning and development functions are often disparate and difficult to integrate. We’re creating adaptive technology to help organizations deliver a unified talent experience that provides the highly engaging learning and continuous performance management that employees and organizations need to fuel personal, career and company growth.” Brandon Hall Group has consistently been the leading independent analyst firm and confirms that Totara Learning offerings measurably benefit the organizations they work with. To learn more about Smartchoice® preferred vendors or to become one, please visit http://go.brandonhall.com/l/8262/2019-11-13/9pst4l. About Brandon Hall Group- Brandon Hall Group is the world’s only professional-development company that provides data, research, insights and certification to Learning and Talent professionals and organizations. The best companies in the world rely on Brandon Hall Group to help create future-proof employee-development plans for the new era of work and management. For more than 27 years, BHG empowers, recognizes and certifies excellence in organizations throughout the world, driving the development of more than 10,000,000 employees and executives. Our annual HCM Excellence Awards program was the first to recognize and celebrate organizations for learning and talent, and as the industry’s gold standard is known as the “Academy Awards of Human Capital Management.” Brandon Hall Group’s cloud-based platform delivers evidence-based insights in Learning and Development, Talent Management, Leadership Development, Diversity and Inclusion, Talent Acquisition and HR/Workforce Management for corporate organizations and HCM solution providers. To learn more, visit http://www.brandonhall.com About Totara Learning Totara builds employee engagement, learning, and performance management technologies that enable large multinational corporations, government entities, and mid-market companies to deliver enterprise-level talent and workforce experiences. Totara’s Talent Experience Platform unifies a transformational learning management system (LMS), a user-centric learning experience platform (LXP), and a comprehensive performance management system under a single and highly adaptable architecture. Totara’s flexible architecture gives organizations the freedom to innovate, the freedom to choose, and unlocks critical resources for reinvestment into where it really counts. Attachment Preferred-Tech-Partner_Bronze_Totara CONTACT: David Forry Brandon Hall Group 5613538082 David.email@example.com
2015 Pro Football Hall of Fame Enshrinee and 1987 Heisman Trophy winner Tim Brown, Hall of Fame Resort & Entertainment Company ("HOFV") (NASDAQ: HOFV, HOFVW) and Elite Holdings, LLC ("Elite"), today announced the development of The Nine, a new, one-of-a-kind documentary which will be produced in partnership with NFL Films. The Nine will profile the individuals who have both won a Heisman Trophy and have been enshrined into the Pro Football Hall of Fame ("H2H athletes").
Revance Issues Inaugural Environmental, Social and Governance (ESG) Report
Estimated $18 Million Per Year of Increased Net Income ($0.75 Earnings Per Share) CUPERTINO, CA, Jan. 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Aemetis, Inc. (NASDAQ: AMTX) announced that its “Carbon Zero” biofuels production process has received a total of $16.8 million of solar energy and other energy efficiency grants to fund upgrades of the Keyes, California plant to support the production of zero carbon renewable fuel. The renewable energy and efficiency projects funded by the grants already have been launched into the design, permitting, construction and commissioning process. The projects supported by grant funding will provide an estimated $18 million per year of increased margin, equal to about $0.75 net income per share each year. Aemetis Carbon Zero production plants commercialize patented technology exclusive to Aemetis for agricultural and forest waste wood feedstock. Carbon Zero plants are integrated with existing Aemetis production facilities to produce energy dense renewable fuels using renewable energy and below zero carbon intensity waste feedstocks. Carbon Zero production plants are designed to convert below zero carbon feedstocks (waste wood and ag wastes) and renewable energy (solar, renewable natural gas, biogas) into energy dense liquid renewable fuels. Aemetis expects that such renewable fuels, when used in hybrid electric vehicles or other vehicle engines, will have a “below zero carbon” greenhouse gas footprint across the entire lifecycle of the fuel based on the Argonne National Laboratory’s GREET model, the pre-eminent science-based lifecycle analysis measurement tool. “The award of a combined $16.8 million of California Energy Commission and Pacific Gas & Electric energy efficiency programs to fund the ‘Carbon Zero 1’ biofuels plant reflects government and utility industry support for our mission to reduce greenhouse gases,” stated Eric McAfee, Chairman and CEO of Aemetis. “We are installing a large solar array with battery storage and using other renewable energy sources to power new electricity-powered systems, replacing equipment that uses high carbon intensity petroleum natural gas and upgrading less efficient heat transfer systems.” “These Carbon Zero plant upgrades at the Keyes plant are an integrated part of producing below zero carbon biofuels from agricultural waste wood,” said McAfee. “By combining below zero carbon waste wood with zero carbon renewable energy obtained from solar, hydroelectric and biogas sources, Aemetis is transforming these sources of renewable energy into zero carbon renewable fuels to power existing engines and to fuel range extender generators used in electric cars and trucks,” McAfee noted. The Carbon Zero 1 plant renewable energy and energy efficiency upgrades include funding and other support from the California Energy Commission, the USDA, the US Forest Service, the California Department of Food and Agriculture, and PG&E. About Aemetis Aemetis has a mission to transform renewable energy into below zero carbon transportation fuels. The next generation of renewable fuels can achieve below zero carbon emissions by addressing the market need of reducing greenhouse gas emissions with sustainable alternatives. Aemetis uses low-carbon renewable resource-based carbohydrates as raw materials and is developing renewable electricity and renewable natural gas for use in transportation and production processes. Aemetis low-carbon fuels have substantially reduced carbon intensity (the level of greenhouse gas emissions compared to standard petroleum fossil-based fuels across their lifecycle). Headquartered in Cupertino, California, Aemetis is a renewable natural gas, renewable fuel and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products. Founded in 2006, Aemetis has completed Phase 1 and is expanding a California biogas digester network and pipeline system to convert dairy waste gas into Renewable Natural Gas (RNG). Aemetis owns and operates a 65 million gallon per year ethanol production facility in California’s Central Valley near Modesto that supplies about 80 dairies with animal feed. Aemetis also owns and operates a 50 million gallon per year production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India and Europe. Aemetis is developing the Carbon Zero 1 plant in California to convert waste orchard wood into sugars that will be processed into biofuels at the Keyes plant, as well as cellulosic ethanol and renewable hydrogen in expansion phases. Aemetis holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit www.aemetis.com. Safe Harbor Statement This news release contains forward-looking statements, including statements regarding our assumptions, projections, expectations, targets, intentions or beliefs about future events or other statements that are not historical facts. Forward-looking statements in this news release include, without limitation, statements related to increased net income, statements relating to our ability to commercialize and scale the licensed patented technology, the ability to obtain sufficiently low Carbon Intensity score to achieve below zero transportation fuel, the development of the Aemetis Biogas Central California Dairy Project, and the ability to access the funding required to execute on the plant construction and operations. Words or phrases such as “anticipates,” “may,” “will,” “should,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “showing signs,” “targets,” “will likely result,” “will continue,” “enable” or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on current assumptions and predictions and are subject to numerous risks and uncertainties. Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions due to certain factors, including, without limitation, competition in the ethanol, biodiesel and other industries in which we operate, commodity market risks including those that may result from current weather conditions, financial market risks, customer adoption, counter-party risks, risks associated with changes to federal policy or regulation, and other risks detailed in our reports filed with the Securities and Exchange Commission (the “SEC”), including the Aemetis Annual Report on Form 10-K for the year ended December 31, 2019, and in our subsequent filings with the SEC. We are not obligated, and do not intend, to update any of these forward-looking statements at any time unless an update is required by applicable securities laws. External Investor Relations Contact:Kirin SmithPCG Advisory Group(646) firstname.lastname@example.org Company Investor Relations/Media Contact:Todd Waltz (408) email@example.com
FREMONT, Calif., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy management technology company and the world’s leading supplier of microinverter-based solar-plus-storage systems, today announced that Enphase Storage systems are now compatible with Enphase M215™ and M250™ microinverter-based solar systems. The expanded compatibility provides approximately 300,000 additional Enphase system owners with the possibility of achieving grid-agnostic energy resilience through the Enphase Upgrade Program. The Enphase Upgrade Program provides solar installers the opportunity to renew engagements with the installed base of Enphase system owners through microinverter, solar, and energy storage upgrades. The program is for owners of Enphase microinverters and represents the Company’s continued commitment to reliability, service, and long-term customer relationships. Participation in the Enphase Upgrade Program is entirely voluntary. Enphase continues to stand by its limited warranties for existing products in the field by leveraging insights into field-deployed products through advanced remote analytics. The compatibility of Enphase Storage systems with M215 and M250 microinverter-based solar systems, as well as with IQ 6™ and IQ 7™ microinverter-based solar systems, now allows installers in the U.S. to approach and offer storage upgrades to nearly the vast majority of Enphase homeowners nationwide. “Our M-Series customers are thrilled to have the option to upgrade their solar systems with Enphase Storage without also having to upgrade their microinverters or solar panels,” said John Orfali, owner at Save A Lot Solar. “We started installing Enphase microinverters about ten years ago, and we have never looked back. The compatibility between Enphase Storage and Enphase M-Series microinverters is just the latest indication that we made the right decision, especially given the need for energy resilience as planned power outages disrupt the lives of the increasing number of people who now work from home.” “We were one of the first solar installers in the U.S. to test the Upgrade Program concept with Enphase in mid-2018, and our customers have been enthusiastic about revitalizing their solar systems with the latest microinverter technology and accompanying limited warranties,” said Chaz Mathias, owner at First Response Solar. “Today, our focus is primarily on serving the strong demand we have in California for solar-plus-storage systems. The Upgrade Program provides a bridge between older systems and the new Enphase Encharge™ storage system, and that is a big win for our customers. Our homeowners also love having a unified dashboard with the Enphase Enlighten™ monitoring system to see their solar energy production, energy usage, and energy storage. As an active volunteer firefighter, Enphase always gives me peace of mind knowing that our installation teams, homeowners, and first responders can safely operate the system without being exposed to high-voltage DC electricity on our installs.” “Solar systems used to be much smaller, and solar technology has come a long way in the past ten years,” said Cory Johnson, owner at New Day Solar. “Our Enphase Upgrade Program participants are pleased about how Enphase stands with its customers in the long term by providing the opportunity to refresh, expand, and upgrade their systems at a significant discount. We have come to appreciate the inbound sales leads the Upgrade Program continues to provide as well as the new customer relationships that are created around these systems’ new limited warranties. Enphase has also made a quantum leap over its competitors in terms of customer support, making its already outstanding microinverter technology a no-brainer for both homeowners and installers.” “As the technology keeps improving and solar systems get older, I feel that the interest in upgrading solar PV systems that are now more than ten years old will continue to grow,” said Courtney Hider, director of operations at Energy Monster. “We believe that it is important to educate both new and existing solar homeowners about ways to make their living spaces more energy-efficient, and the Enphase Upgrade Program is another tool that helps us do that. Efficient, modern solar systems help the environment and the customer's wallet, which is what we are all about.” “The Enphase Upgrade Program has provided homeowners a path to upgrade or replace older Enphase solar systems, and during the COVID-19 pandemic, it has been a source of work, revenue, and jobs for solar installers,” said Dave Ranhoff, chief commercial officer at Enphase Energy. “We are grateful for all the solar installers who continue to be outstanding partners in helping Enphase deliver on a service program that makes a difference in people’s lives. We also welcome the many Enphase M-Series system owners to the family of homeowners who now can make a simple upgrade towards true energy independence with Encharge Storage systems.” Program details are available in Enphase installer and homeowner webinars and on the Enphase Upgrade Program website. About Enphase Energy, Inc. Enphase Energy, a global energy technology company, delivers smart, easy-to-use solutions that manage solar generation, storage and communication on one intelligent platform. The Company revolutionized the solar industry with its microinverter technology and produces a fully integrated solar-plus-storage solution. Enphase has shipped more than 30 million microinverters, and approximately 1.3 million Enphase-based systems have been deployed in more than 130 countries. For more information, visit www.enphase.com and follow the company on Facebook, LinkedIn and Twitter. Enphase Energy, Enphase, the E logo, M-Series, M215, M250, IQ 6, IQ 7, Encharge, Enlighten, and other trademarks or service names are the trademarks of Enphase Energy, Inc. Other names are for informational purposes and may be trademarks of their respective owners. Forward-Looking Statements This press release may contain forward-looking statements, including statements related to the expected capabilities and performance of Enphase Energy’s technology and products, including safety, quality and reliability and energy independence; our customer service and the quality of service provided by our installation partners; the anticipated market adoption of and the cost savings from our current and future products; and the availability of the Program or installations given certain shelter-in-place orders and/or other regulations. These forward-looking statements are based on Enphase’s current expectations and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of certain risks and uncertainties, including those risks described in more detail in Enphase’s most recent Annual Report on Form 10-K and other documents on file with the SEC and available on the SEC’s website at www.sec.gov. Enphase Energy undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events, or changes in its expectations, except as required by law. Contact: Christian Zdebel, firstname.lastname@example.org, 484-788-2384
PLANO, Texas, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Green Brick Partners, Inc. (Nasdaq: GRBK), a leading national homebuilder and land development company, today announced certain record financial and operational results for the fourth quarter and full year 2020. Jim Brickman, CEO, stated, “2020 was a breakout year for Green Brick and we believe that we are well positioned to deliver strong growth again in 2021. We expect to report diluted earnings per share between $2.21 and $2.23 for 2020, an increase of over 90% from 2019. During the quarter, our record 848 net new orders occurred at all home builder brands and price points, outpacing our available inventory. We ended the quarter with a $687 million backlog - the highest in our history and up 98% year over year. We reacted to the supply shortage quickly and started a record breaking 1,004 homes in the fourth quarter which is up 99% over the same prior period. Put simply, short-term demand exceeded our supply, and we have rapidly expanded our capacity. Net new orders have further accelerated with 238 homes sold in the first eighteen days of January 2021 (up 98% over the same prior period in 2020) making this the strongest sales period in our company’s history.” Full Year 2020 Preliminary Financial and Operational Highlights – Comparisons to the Prior Year PeriodPreliminary financial results for Green Brick’s fiscal year ending December 31, 2020 are expected as follows: Diluted earnings per share between $2.21 and $2.23, an increase between 90.5% and 92.2%;Net income attributable to Green Brick between $112.5 million and $113.5 million, an increase between 91.8% and 93.5%;Income before income taxes and noncontrolling interests between $142.1 million and $143.5 million, an increase between 68.5% and 70.2%;Residential units revenue between $929.0 million and $931.0 million, an increase between 22.3% and 22.5%;Gross margin in a range of 24.0% to 24.2%, an increase between 260 and 280 basis points;Backlog as of December 31, 2020 was $686.9 million, an increase of 98% compared to $346.8 million as of December 31, 2019; and,Homes under construction increased to 1,780 units as of December 31, 2020, a 37.2% increase compared to 1,297 as of December 31, 2019. Select Fourth Quarter 2020 and Full Year 2020 Operational Results New homes delivered were 585 for the fourth quarter, a 13.8% increase over the prior year. New homes delivered for the full year ended December 31, 2020 were 2,208 and represented a 28.4% increase over the prior year.Net new orders were 848 homes for the fourth quarter, a 43.7% increase over the prior year. Net new orders for the full year ended December 31, 2020 were 2,885 homes and represented a 50% increase over the prior year.Average active selling communities increased to 102 communities for the fourth quarter from 90 communities for the quarter ended December 31, 2019, an increase of 13.3%. Rick Costello, CFO, added, “In order to accommodate expected growth in 2021 and beyond, our owned and controlled lots grew to 14,468 lots at year end, a 61% increase over our lot supply at our prior year end. Despite the significant cashflow required for this ramp-up in production, we ended the year with total debt $18 million lower than the prior year end. In summary, we believe the company is well-prepared to capture very strong demand.” These preliminary, unaudited financial estimates are based on information available to management as of the date of this press release, remain subject to the completion of normal quarter-end accounting procedures and adjustments, and are subject to change. Green Brick’s independent registered public accounting firm has not completed its audit of our results for the year ended December 31, 2020. During the course of the preparation of our consolidated financial statements and related notes, and completion of our financial close and audit procedures for the twelve months ended December 31, 2020, adjustments to the preliminary estimates may be identified, and such adjustments may be material. In addition, other developments may arise between now and the time the financial statements for the twelve months ended December 31, 2020 are finalized. We undertake no obligation to update the information in this press release in the event facts or circumstances change after the date of this press release. Green Brick Partners plans to release its financial results for the fourth quarter and full year ended December 31, 2020 on Monday, March 8, 2021, after the close of the U.S. financial markets. We will host an earnings conference call on Tuesday, March 9, 2021 at 12:00 PM Eastern Time. About Green Brick Partners, Inc. Green Brick Partners, Inc. (Nasdaq: GRBK) is a diversified homebuilding and land development company. Green Brick owns four homebuilders in Dallas, Texas (CB JENI Homes, Normandy Homes, Southgate Homes, Trophy Signature Homes), as well as a controlling interest in homebuilders in Atlanta, Georgia (The Providence Group), Port St. Lucie, Florida (GHO Homes), and Dallas, Texas (Centre Living Homes). Green Brick also owns a noncontrolling interest in Challenger Homes in Colorado Springs, Colorado and retains interests in related financial services platforms, including Green Brick Title, Providence Group Title, and Green Brick Mortgage. The Company is engaged in all aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, and sales for its residential neighborhoods and master planned communities. For more information about Green Brick’s homebuilding partners and financial services platforms, please visit https://greenbrickpartners.com/team-builders/. Forward-Looking and Cautionary Statements:This press release and our earnings call contain “forward-looking statements” within the meaning of the Private Securities Litigation Act of 1995. These statements concern expectations, beliefs, projections, plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts and typically include the words “anticipate,” “believe,” “consider,” “estimate,” “expect,” “forecast,” “intend,” “objective,” “plan,” “predict,” “projection,” “seek,” “strategy,” “target,” “will” or other words of similar meaning. Forward-looking statements in this press release include management’s estimates of fourth quarter and full year 2020 financial and operational results and management's belief that it is well positioned to deliver strong growth in 2021. These forward-looking statements involve estimates and assumptions which may be affected by risks and uncertainties in the Company’s business, as well as other external factors, which could cause future results to materially differ from those expressed or implied in any forward-looking statement. These risks include, but are not limited to: (1) adverse impacts from general economic conditions, including as a result of the COVID-19 pandemic and the responsive actions taken by federal, state and local public health and governmental authorities, seasonality, cyclicality and competition in the homebuilding industry; (2) changes in consumer price sensitivity or decreased demand for the Company’s homes or finished lots or increases in cancellations, including as a result of the COVID-19 pandemic; (3) availability and cost of labor; (4) a failure to recruit, retain or develop highly skilled and competent employees; (5) availability and cost of raw materials or other supplies, necessary for our homebuilding activities, and the impact of the COVID-19 pandemic on global supply chains; (6) an inability to acquire land for reasonable prices; (7) an inability to develop or sell communities; (8) government regulation risks; (9) a lack of availability or volatility of mortgage financing; (10) a severe weather event or natural disasters; (11) difficulty in obtaining sufficient capital; (12) poor relations with community residents; and (13) an increase in our debt levels or related service obligations. For a more detailed discussion of these and other risks and uncertainties applicable to the Company please see the Company’s Annual Report on Form 10-K and the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2020 filed with the Securities and Exchange Commission. Contact: Richard A. CostelloChief Financial Officer(469) 573-6755
CAMBRIDGE, Mass., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced the grant of an inducement award to the newly appointed Senior Vice President and Chief Human Resources Officer, Carla Poulson. In connection with the appointment, the Compensation Committee of the Board of Directors of Mersana Therapeutics approved a stock option grant to Ms. Poulson as an inducement material to Ms. Poulson entering into employment with Mersana Therapeutics, in accordance with Nasdaq Listing Rule 5635(c)(4). The stock option grant provides for the purchase of up to 100,000 shares of Mersana Therapeutics common stock, at a price of $21.67 per share, the closing price per share of Mersana Therapeutics common stock on the date of grant, and vests over four years, with 25% of the shares vesting on the first anniversary of the Ms. Poulson’s employment start date, and the remainder vesting in equal quarterly installments over the following three years, subject to Ms. Poulson’s continued employment with Mersana Therapeutics through such applicable vesting dates. About Mersana TherapeuticsMersana Therapeutics is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to rapidly develop novel ADCs with optimal efficacy, safety and tolerability to meaningfully improve the lives of people fighting cancer. Mersana’s lead product candidate, XMT-1536, is in the expansion portion of a Phase 1 proof-of-concept clinical study in patients with ovarian cancer and NSCLC adenocarcinoma. XMT-1592, Mersana’s second ADC product candidate targeting NaPi2b-expressing tumors, was created using Mersana’s customizable and homogeneous Dolasynthen platform and is in the dose escalation portion of a Phase 1 proof-of-concept clinical study. The Company’s early stage programs include XMT-1660, a Dolasynthen ADC targeting B7-H4, as well as XMT-2056, a STING-agonist ADC developed using the Company’s Immunosynthen platform. In addition, multiple partners are using Mersana’s Dolaflexin platform to advance their ADC pipelines. Contact: Investor & Media ContactSarah Carmody, email@example.com
Press Release 22 January 2021 Report from the Extraordinary General Meeting of Immunicum AB (publ) on 22 January 2021 At the Extraordinary General Meeting (the “EGM”) of Immunicum AB (publ) (IMMU.ST) on 22 January 2021 the EGM adopted, inter alia, the following resolutions. For more detailed information regarding the contents of the resolutions, please refer to the notice to the EGM and the complete proposals, which have previously been published and are available on the company’s website, www.immunicum.com. Election of Board of Directors and approval of remuneration to the Board Prior to the EGM, Van Herk Investments B.V. (“Van Herk”) had proposed that the Board would be composed of eight (8) ordinary board members without deputies through election of Dharminder Chahal and Andrea van Elsas as new board members and that current chairman Michael Oredsson and the board members Sven Andreasson, Charlotte Edenius, Steven Glazer, Christine Lind and Helén Tuvesson would remain in the Board. In light of Michael Oredsson’s resignation from his position as chairman, as well as the Board’s appointment of Christine Lind as interim chairman for the period until the next Annual General Meeting as announced by press release on 21 January 2021, the EGM resolved that the Board shall be composed of seven (7) ordinary board members without deputies. The EGM resolved to elect Dharminder Chahal and Andrea van Elsas as new board members and that Sven Andreasson, Charlotte Edenius, Steven Glazer, Christine Lind and Helén Tuvesson shall remain in the Board for the period until the next Annual General Meeting. Further, it was resolved in accordance with Van Herk’s proposal that Andrea van Elsas and Dharminder Chahal shall receive the same remuneration as the other board members in the company, i.e., SEK 150,000 on an annual basis. The remuneration shall be adjusted pro rata based on the time from their election as board members up until the Annual General Meeting 2021. The information in this press release is information that Immunicum AB (publ) is obliged to disclose pursuant to Nasdaq Stockholm’s Rule Book for Issuers. The information was released for public disclosure through the contact person detailed below on 22 January 2021 at 14:00 CET. For more information, please contact: Christine Lind, Interim Chairman of the Board of DirectorsTelephone: +46 8 732 8400E-mail: firstname.lastname@example.org About Immunicum AB (publ) Immunicum is leveraging its unparalleled expertise in dendritic cell biology to develop novel, off-the-shelf, cell-based therapies for solid and blood-borne tumors. With complementary therapeutic approaches in Phase II clinical development that are based on intratumoral priming and cancer relapse vaccination, the company aims to improve survival outcomes and quality of life for a broad population of cancer patients. Based in Sweden and the Netherlands, Immunicum is publicly traded on the Nasdaq Stockholm. www.immunicum.com Attachment 20210122 Immunicum EGM Report (Delphi 210121)(16740248.1)_FINAL
MINNEAPOLIS, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that it has entered into definitive agreements with several institutional and accredited investors for the issuance and sale of an aggregate of approximately 3,414,970 shares of its common stock, at a purchase price of $1.20 per share, for gross proceeds of approximately $4.1 million in a registered direct offering priced at-the-market under Nasdaq rules. Predictive Oncology has also agreed to issue to the investors unregistered warrants to purchase up to an aggregate of approximately 1,707,485 shares of common stock. The closing of the offering is expected to occur on or about January 26, 2021, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The warrants have an exercise price equal to $1.37 per share, are exercisable immediately upon issuance and will expire five and one-half years from the issuance date. The Company currently intends to use the net proceeds from the offering for working capital purposes. The shares of common stock described above are being offered and sold by the Company in a registered direct offering pursuant to a “shelf” registration statement on Form S-3 (Registration No. 333-234073), including a base prospectus previously filed with the Securities and Exchange Commission (the “SEC”) on October 3, 2019 and became effective on December 19, 2019. The offering of the shares of common stock will be made only by means of a prospectus supplement that forms a part of the registration statement. A final prospectus supplement and base prospectus relating to the registered direct offering will be filed with the SEC and will be available on the SEC's website located at http://www.sec.gov. Electronic copies of the prospectus supplement and the accompanying base prospectus may also be obtained by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by phone at 646-975-6996 or e-mail at email@example.com. The warrants described above were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Act"), and Regulation D promulgated thereunder and, along with the shares of common stock underlying the warrants, have not been registered under the Act, or applicable state securities laws. Accordingly, the warrants and the underlying shares of common stock may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Act and such applicable state securities laws. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Predictive Oncology Inc. Predictive Oncology (NASDAQ: POAI) operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. TumorGenesis Inc. specializes in media that help cancer cells grow and retain their DNA/RNA and proteomic signatures, providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. Skyline Medical markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. Soluble Biotech is a provider of soluble and stable formulations for proteins including vaccines, antibodies, large and small proteins and protein complexes. For more information, please visit www.predictive-oncology.com. Forward-looking Statements Certain of the matters discussed in this press release contain forward-looking statements that involve material risks to and uncertainties in the Company’s business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include: market and other conditions, the completion of the registered direct offering, the satisfaction of customary closing conditions related to the registered direct offering and the intended use of net proceeds from the registered direct offering, a variety of other risks and uncertainties including, among other things, factors discussed under the heading “Risk Factors” in our filings with the SEC. Except as expressly required by law, the Company disclaims any intent or obligation to update these forward-looking statements. Investor Relations Contact: Landon CapitalKeith Pinder(404) firstname.lastname@example.org
Locast launches streaming local TV channels in Orlando. Orlando viewers can now stream all of their local TV channels on their phones, tablets, computers or streaming media players. Locast offers local channels airing conference playoff football games Sunday Nonprofit is only service to stream all local TV channels – for free – over internet ORLANDO, Fla., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Locast, America’s only nonprofit, free, local broadcast TV digital translator streaming service, is delivering more than 70 local TV channels via the internet – for free – to more than 4 million residents living in the greater Orlando TV market in central Florida, starting today. It’s the fourth Florida market for Locast, joining Miami, Tampa Bay, and West Palm Beach. For the first time, residents in Orlando and the surrounding cities and suburbs, including Daytona Beach and Melbourne, will be able to watch all of their local TV stations via the Internet on their phones, tablets, laptops, or streaming media devices. Locast provides a public service by giving access to important local news, storm coverage, emergency information, health and safety updates, election coverage, sports, and entertainment programming to internet-connected devices. Through its local TV channel service, Locast offers this Sunday’s pro-football conference playoff games. So-called “cord cutters,” who cancel their increasingly expensive pay-TV subscriptions, and “cord-nevers,” who have never subscribed to pay-TV services, represent a significant proportion of Locast users. For those who cannot afford pay-TV or cannot receive an over-the-air signal, Locast is often their only link to local broadcast news, emergency information, weather, sports, and entertainment. As a nonprofit, Locast performs a critical public service by increasing access to local broadcast channels – on the go, over the internet, on any device. Locast delivers more than 70 local TV channels in the Orlando designated market area (DMA), including WESH NBC 2, WOFL FOX 35, WFTV ABC 9, WKMG CBS 6, PBS and PBS Kids as well as The Florida Channel, CourtTV, AntennaTV, Telemundo, Univision, Azteca America, Estrella TV, The CW, BOUNCE, Movies!, My Network TV, LAFF, Mystery, GRIT, ION, CometTV, True Crime, Charge!, and more. Locast is accessible to viewers in nine counties in the Orlando-Daytona Beach-Melbourne DMA including Brevard, Flagler, Lake, Marion, Orange, Osceola, Seminole, Sumter, and Volusia. Locast was started by consumer advocate David Goodfriend, a Washington, D.C.-based attorney who founded the nonprofit advocacy organization, Sports Fans Coalition, in 2009 and fought the NFL and large media companies by petitioning the FCC to end the 40-year-old, anti-fan Sports Blackout Rule. Sports Fans Coalition won in 2014 when the FCC voted unanimously to end the practice, giving fans greater access to watch their local football team. Goodfriend founded Locast in 2018. Locast has more than 2.3 million registered users nationwide in 28 markets – large and small – reaching nearly half of the U.S. population. In 2020, Locast added more than 1 million users, making it one of the fastest-growing live TV streaming services and was named 2020’s most improved streaming service by TechHive. Compared to most streaming services, which charge fees, Locast is free. Locast operates under the Copyright Act of 1976 that allows nonprofit translator services to rebroadcast local stations without receiving a copyright license from the broadcaster. The federal statute (17 U.S.C. 111(a)(5)) states that a nonprofit organization may retransmit a local broadcast signal and collect a fee to cover the cost of operations. Locast asks viewers to donate as little as $5 per month to help cover operating costs. The donation is voluntary and not required. Locast is available for streaming at www.locast.org, app stores, TiVo, streaming service providers Google Play, Apple TV, Android TV, Amazon, and ROKU, and on DISH Hopper/Wally receivers or select DIRECTV receivers. Locast also offers Spanish-language access to the Locast app’s user-interface, log-in screens, and program guide. Complete local TV guides are available at www.locast.org. About LocastLocast.org was founded by Sports Fans Coalition NY (SFCNY), a New York-based nonprofit, fan-advocacy group formed in 2017. Locast launched in 2018 and is available in 28 DMAs. SFCNY is the first local chapter of Sports Fans Coalition, Inc., which led the successful campaign to end the FCC’s Sports Blackout Rule and continues to advocate for fans. TechHive named Locast the most-improved streaming service of 2020. As a nonprofit, Locast is supported by user donations and is available at www.locast.org. Follow Locast on Facebook and Twitter @LocastOrg. Locast press contact:PR@locast.org A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/cd1933e7-244e-445e-bc50-f4d4340920fd
Funded by Amgen, Astellas, Bristol Myers Squibb, GSK, Janssen, Lilly, Pfizer, Roche, Sanofi and Takeda The companies will support the rollout of a cloud-based platform with the potential to transform the way the biopharma industry communicates and exchanges information with health authorities worldwide. BURLINGAME, Calif., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Ten of the world’s leading biopharmaceutical companies today announced the formation of a new non-profit corporation, Accumulus Synergy, Inc., which is intended to support interactions between industry and health authorities worldwide to enable real-time collaboration and data exchange, as well as data submission. Accumulus Synergy was formed on July 13, 2020, to develop a cloud-based platform to facilitate data and information sharing with the potential to transform the way the biopharmaceutical industry interacts with health authorities. The common-platform approach to data sharing aims to make the regulatory process more efficient by leveraging advanced technology and tools for data exchange to benefit patients, help reduce the cost of innovation and ultimately bring patients new safe and effective medicines faster. “Current methods for data exchange and communication between pharmaceutical companies and global health authorities have not kept pace with advancements in information technology,” said Francisco Nogueira, interim Chief Executive Officer of Accumulus Synergy and Vice President of Regulatory Affairs at Roche. “In consultation with health authorities, Accumulus Synergy seeks to modernize, integrate, and streamline communication and data exchange between biopharmaceutical companies and global regulators, as well as to facilitate potential regulatory harmonization in priority areas, using the latest in cloud technology. By creating a powerful data-sharing ecosystem, we have the potential to advance delivery of healthcare. Accumulus Synergy looks to create significant value for patients, healthcare providers, health authorities, and biopharma companies globally.” The initial members of Accumulus Synergy include Amgen, Astellas, Bristol Myers Squibb, GSK, the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), Lilly, Pfizer, Roche, Sanofi, and Takeda, which have provided funding to support the platform and initial applications. Accumulus Synergy plans to consult with the Japanese Pharmaceutical and Medical Devices Agency, the European Medicines Agency, the U.K. Medicines and Healthcare products Regulatory Agency, and the U.S. Food and Drug Administration, as well as other health authorities worldwide. “I am very excited to see Accumulus progress after over a year of careful planning,” said Mikael Dolsten, Chief Scientific Officer and President, Worldwide Research, Development and Medical at Pfizer. “This project reflects the importance of collaboration among stakeholders to improve pharmaceutical development, with the potential to enable faster and more efficient exchange of information and data with health authorities.” “Collaborations focused on science and advanced technologies make us more efficient and ultimately accelerate our ability to improve outcomes for patients – an approach Sanofi has fully embraced,” said John Reed, Executive Vice President, Global Head of Research & Development at Sanofi. “Accumulus’ coordinated efforts to lead data-sharing solutions will reduce the time it takes to make innovative new medicines available to patients, and that’s a goal worthy of support.” “The Accumulus Synergy vision is transformative. Accumulus Synergy will proactively engage global health authorities in building a cloud platform to enable efficient filing and review of documents and data. Importantly, Accumulus will build upon and complement the collaborative efficiency solutions developed by TransCelerate BioPharma, Inc. This will result in an acceleration of medicine access across geographies and reduce drug lag,” added Paul Stoffels, Chief Scientific Officer, Johnson & Johnson. “We are pleased to see Accumulus advance its strategic objective to transform communication and data exchange between biopharma companies and health authorities, an effort complementary to the objectives of TransCelerate Biopharma. We look forward to our continued collaboration with Accumulus in areas of common interest,” said Dalvir Gill, Chief Executive Officer, TransCelerate Biopharma. “Health authorities, physicians, and biopharmaceutical companies all share a common purpose to bring safe, transformative medicines to patients as quickly as possible,” added Andy Plump, M.D., Ph.D., President of Research & Development at Takeda. “Accumulus Synergy is an opportunity to reimagine regulatory and data-sharing pathways globally and better deliver on that purpose.” About Accumulus Synergy Funded by ten leading biopharma companies, the non-profit Accumulus Synergy, Inc. was formed in 2020 to create a cloud-based platform, to transform data sharing between the biopharma industry and global health authorities. The common-platform approach aims to improve efficiencies in the regulatory process by leveraging advanced technology, including data science and AI, as well as tools for data exchange to improve patient safety, help reduce the cost of innovation, and ultimately bring patients safe and effective medicines faster. It will work with partner companies, key stakeholders, and global health authorities to build and sustain a platform that meets regulatory, cybersecurity, and privacy requirements spanning clinical, safety, chemistry and manufacturing, and regulatory exchanges and submissions. For more information, please visit www.accumulus.org. Media Contact: Paul Laland Paul.email@example.com 415.519.6610
Korn Ferry (NYSE: KFY), a global organizational consulting firm, today announced the expansion of its presence in Russia with the addition of an experienced team of executive search and organizational consulting professionals. The addition of the new consultants will immediately increase Korn Ferry’s breadth and depth of capabilities and enhance Korn Ferry’s ability to impact clients in the region.
Office Properties Income Trust (Nasdaq: OPI) today announced that it will issue a press release containing its fourth quarter 2020 financial results after the Nasdaq closes on Thursday, February 18, 2021. On Friday, February 19, 2021 at 10:00 a.m. Eastern Time, President and Chief Operating Officer Christopher Bilotto and Chief Financial Officer Matthew Brown will host a conference call to discuss these results.